Stocks in Focus (ZAGG,NBEV,AAPL,HEAR,CRSP)

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Zagg Inc (NASDQ:ZAGG) jumped to $8.70 Wednesday on a big volume spike. It was a quick up and down but looks like it’s a good sing. These random spikes are becoming more and more regular and it makes me think some big shorts want out with the looming rumor of takeover interest. Earnings are a few weeks out so I’ll be looking for profit between now and then.

New Age Beverages Corp (NASDAQ:NBEV) etched a nice up, in, up again pattern Thursday so I’m hoping it makes a go for the recent high.

Apple Inc (NASDAQ:AAPL) squeeze is really coming together nicely off the 21 EMA Wednesday but the fact the stock basically covered the gap already is a really good sign this could fire soon. 

Turtle Beach Corp (NASDAQ:HEAR) is nearly oversold after the company reported weak earnings. It’s not my typical fish hook in that it hasn’t fallen -50% or more in under a month but since November it’s down from $12 so this $7 area is one that I’m starting to watch. Bounces don’t tend to be huge out of oversold but they do tend to predictable with one or two big candles so I’ll start to scout for entry.

Groupon Inc Common Stock (NASDAQ:GRPN) is at the top of my list after a massive -44% drop Wednesday. I wonder if they regret kicking out the founder many years ago?! Wednesday was clearly too early to take a stab at this as shares closed at the lows and I’m not even sure it’ll setup this week, however, I’m watching for the fish hook. 

Crispr Therapeutics AG (NASDAQ:CRSP) 8 EMA is crossing the 21 EMA so I’ll be looking for an ITM directional Call option a few months out. They had a good earnings call recently and I think a trend will ensue.